News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
23andMe
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
23andMe, Inc. And FDA Find A Way To Work Together In Shifting Political Atmosphere
July 1, 2014
·
1 min read
Biotech Bay
23andMe, Inc. Pursues Health Research In The Shadow Of The FDA
March 27, 2014
·
1 min read
Biotech Bay
23andMe, Inc. Is Still Under FDA Review, But Here’s Their Next Move
March 11, 2014
·
1 min read
BioCapital
How FDA and 23andMe, Inc. Dance Around Evidence That Is Not There
January 28, 2014
·
1 min read
Biotech Bay
Personal Gene Tests Face Stricter Oversight After 23andMe, Inc.
December 12, 2013
·
1 min read
Biotech Bay
FDA’s Culture Is Genetically Dominant Over 23andMe, Inc.’s Business Model
December 6, 2013
·
1 min read
Biotech Bay
23andStupid: Is 23andMe, Inc. Self-Destructing?
November 26, 2013
·
1 min read
Biotech Bay
For 23andMe, Inc., The Real Value Could be in its Data
June 13, 2013
·
1 min read
Biotech Bay
New Genetic Discoveries Related to Male Pattern Baldness Found, 23andMe, Inc. Reveals
June 20, 2012
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Bay
23andMe to Present at Upcoming Investor Conferences in November 2022
October 12, 2022
·
3 min read
Biotech Bay
23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
October 5, 2022
·
4 min read
Business
Daniel Chu Joins 23andMe as Chief Product Officer
September 19, 2022
·
3 min read
Biotech Beach
Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki
August 22, 2022
·
3 min read
Business
23andMe Reports FY2023 First Quarter Financial Results
August 8, 2022
·
18 min read
Business
23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results
May 26, 2022
·
23 min read
Business
23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results
May 12, 2022
·
3 min read
Biotech Bay
23andMe to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
March 15, 2022
·
4 min read
Biotech Bay
23andMe to Present at Cowen 42nd Annual Health Care Conference
February 25, 2022
·
3 min read
Biotech Bay
23andMe to Present at Citi’s 2022 Virtual Healthcare Conference
February 17, 2022
·
3 min read